immunitoAI
AI-driven antibody design for therapeutic development.
immunitoAI’s platform generates novel antibody sequences optimized for target binding, specificity, and developability. Researchers specify disease targets and receive candidate molecules in silico, accelerating lead discovery and reducing lab screening time.
Related
2by4
2by4
Your autonomous pre-construction team.
Starting with estimates.
8x
8x
Human orchestration for business outcomes.
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.